Cognitive Rehabilitation for Cancer Survivors with Perceived Cognitive Impairment

The University of Sydney0 sites65 target enrollmentSeptember 28, 2012

Overview

No summary available.

Registry

who.int

Start Date

September 28, 2012

End Date

February 11, 2022

Last Updated

4 years ago

Study Type

Interventional

Sex

All

Sponsor

•1Diagnosis of invasive solid tumour cancer for which definitive treatment was performed within the last 5 years
•2Completed at least 3 cycles of chemotherapy
•3Aged \>17 years
•4A NO” response recorded for the Single Item Cognitive Impairment Question
•5Speak fluent English and read to a year 8 standard.
•6Give written informed consent.
•7Chemotherapy, radiotherapy, immunotherapy (e.g. trastuzumab and/or lapatinib) received must have been completed at least 6 months prior to randomisation.
•8Hormonal treatment (including tamoxifen or an aromatase inhibitor) is permitted as long as treatment has been commenced at least 4 weeks prior to randomisation and is not likely to be ceased within 6 months of randomisation.

•1, ECOG Performance Status of \> 2
•2, Any evidence of extra\-nodal metastatic disease.
•3, Any major pre\-existing neurological condition, co\-morbidity, psychiatric history or substance abuse that could interfere with their ability to perform cognitive testing.
•4, Prior malignancy within the last 5 years (other than non\-melanomatous skin cancer or cervical cancer in\-situ) or previous chemotherapy other than adjuvant or neoadjuvant breast cancer treatment.